Improving healthcare through collaboration.

Through close collaboration with healthcare providers and key opinion leaders, employers, payers, government regulatory authorities, and industry partners, Tethys is working to improve human health and lower the cost of healthcare and the consumption of healthcare resources. The development of breakthrough risk stratification tools that can facilitate the preemption of preventable chronic cardiometabolic diseases represents a major milestone in this endeavor.

The power of partnership.

Tethys is committed to bettering the lives of individuals at risk for cardiometabolic diseases. To that end, the company is building a sustainable, future-focused business grounded in innovation, integrity, sound science and the development of practical clinical tools that enable the preemption of preventable cardiometabolic diseases. 

Tethys recognizes that its ability to achieve its business objectives and deliver on its commitment can be enhanced through strategic alliances with industry partners and organizations who have a shared vision, aligned business objectives, a common customer base, synergistic marketing and distribution capabilities, and a willingness to engage in collaborative partnerships that can extend the companies’ respective corporate reaches.

For more information about regarding collaborative opportunities, please call 510-420-6700.